Inhibitory effect of ginsenoside-Rd on carrageenan-induced inflammation in rats

Canadian Journal of Physiology and Pharmacology

Volumn 90, Issue 2, 2012, Pages 229-236

  Wang, Li ^a   Zhang, Yunxin ^a   Wang, Zhiping ^a   Li, Sijia ^a   Min, Guangning ^a   Wang, Lihua ^a   Chen, Jiajia ^a   Cheng, Junjun ^a   Wu, Yongjie ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Anti inflammation; Carrageenan; Ginsenoside Rd; Nuclear factor B; Phosphorylation of I B ; Proinflammatory cytokines; Proinflammatory mediators

Indexed keywords

CARRAGEENAN; GINSENOSIDE RD; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; NITRIC OXIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG INHIBITION; FEMALE; INFLAMMATION; MALE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARRAGEENAN; CYTOKINES; DINOPROSTONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GINSENOSIDES; I-KAPPA B PROTEINS; INFLAMMATION; INFLAMMATION MEDIATORS; INJECTIONS, INTRAMUSCULAR; MALE; NF-KAPPA B; NITRIC OXIDE; PHOSPHORYLATION; RATS; RATS, WISTAR; TIME FACTORS;

EID: 84863179803     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y11-127     Document Type: Article

References (36)

1. Andreakos, E., Foxwell, B., and Feldmann, M. 2004. Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation? Immunol. Rev. 202(1): 250-265. doi:10.1111/j.0105-2896.2004.00202.x.PMID:15546398
2. Bondeson, J. 1997. The mechanisms of action of disease-modifying antirheumatic drugs: a review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines. Gen. Pharmacol. 29(2): 127-150. PMID:9251892
3. Choi, K., Kim, M., Ryu, J., and Choi, C. 2007. Ginsenoside compounds K and Rh2 inhibit tumor necrosis factor-α-induced activation of the NF-kB and JNK pathways in human astroglial cells. Neurosci. Lett. 421(1): 37-41. doi:10.1016/j.neulet.2007.05.17. PMID:17548155
4. Davies, N.M., Saleh, J.Y., and Skjodt, N.M. 2000. Detection and prevention of NSAID-induced enteropathy. J. Pharm. Pharm. Sci. 3(1): 137-155. PMID:10954683
5. Dayer, J.M. 2004. The process of identifying and understanding cytokines: from basic studies to treating rheumatic diseases. Best Pract. Res. Clin. Rheumatol. 18(1): 31-45. doi:10.1016/j.berh.2003.09.009. PMID:15123036
6. Dudhgaonkar, S., Thyagarajan, A., and Sliva, D. 2009. Suppression of the inflammatory response by triterpenes isolated from the mushroom Ganoderma lucidum. Int. Immunopharmacol. 9(11): 1272-1280. doi:10.1016/j.intimp.2009.07.011. PMID:19651243
7. Guan, Y.Y., Zhou, J.G., Zhang, Z., Wang, G.L., Cai, B.X., Hong, L., et al. 2006. Ginsenoside-Rd from panax notoginseng blocks Ca2+ influx through receptor-and store-operated Ca2+ channels in vascular smooth muscle cells. Eur. J. Pharmacol. 548(1-3): 129-136. doi:10.1016/j.ejphar.2006.08.001. PMID:16973156.
8. James, M.W., and Hawkey, C.J. 2003. Assessment of non-steroidal anti-inflammatory drug (NSAID) damage in the human gastrointestinal tract. Br. J. Clin. Pharmacol. 56(2): 146-155. doi:10.1046/j.1365-2125.2003.01934.x. PMID:12895187
9. Lee, J.H., Kim, S.R., Bae, C.S., Kim, D., Hong, H., and Nah, S. 2002. Protective effect of ginsenosides, active ingredients of Panax ginseng, on kainic acid-induced neurotoxicity in rat hippocampus. Neurosci. Lett. 325(2): 129-133. doi:10.1016/S0304-3940(02)00256-2. PMID:12044638
10. Li, S.W., Westwick, J., and Poll, C.T. 2002. Receptor-operated Ca2+ influx channels in leukocytes: A therapeutic target? Trends Pharmacol. Sci. 23(2): 63-70. doi:10.1016/S0165-6147(00)01897-6. PMID:11830262
11. Li, L., Zhang, J.L., Sheng, Y.X., Guo, D.A., Wang, Q., and Guo, H.Z. 2005. Simultaneous quantification of six major active saponins of Panax notoginseng by high-performance liquid chromatography- UV method. J. Pharm. Biomed. Anal. 38(1): 45-51. doi:10.1016/j.jpba.2004.12.002. PMID:15907618
12. MacMicking, J., Xie, Q.W., and Nathan, C. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15(1): 323-350.doi:10.1146/annurev.immunol.15.1.323. PMID:9143691.
13. Masferrer, J.L., Zweifel, B.S., Manning, P.T., Hauser, S.D., Leahy, K. M., Smith, W.G., et al. 1994. Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. U.S.A. 91(8): 3228-3232. doi:10.1073/pnas.91.8.3228. PMID:8159730
14. Morris, C.J. 2003. Carrageenan-induced paw edema in the rat and mouse. Methods Mol. Biol. 225: 115-121. PMID:12769480
15. Oh, G.S., Pae, H.O., Choi, B.M., Seo, E.A., Kim, D.H., Shin, M.K., et al. 2004. 20(S)-Protopanaxatriol, one of ginsenoside metabolites, inhibits inducible nitric oxide synthase and cyclooxygenase-2 expressions through inactivation of nuclear factor-κB in RAW 264.7 macrophages stimulated with lipopolysaccharide. Cancer Lett. 205(1): 23-29. doi:10.1016/j.canlet.2003.09.037. PMID:15036657
16. Ohshima, H., and Bartsch, H. 1994. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res. 305(2): 253-264.PMID:7510036.
17. Parekh, A.B., and Penner, R. 1997. Store depletion and calcium influx. Physiol. Rev. 77(4): 901-930. PMID:9354808
18. Park, E.K., Choo, M.K., Han, M.J., and Kim, D.H. 2004. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int. Arch. Allergy Immunol. 133(2): 113-120. doi:10.1159/000076383. PMID:14739579
19. Park, E.K., Shin, Y.W., Lee, H.U., Kim, S.S., Lee, Y.C., Lee, B.Y., and Kim, D.H. 2005. Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosynthesis of RAW264.7 cells induced by lipopolysaccharide. Biol. Pharm. Bull. 28(4): 652-656. doi:10.1248/bpb.28.652. PMID:15802804
20. Park, J.S., Park, E.M., Kim, D.H., Jung, K., Jung, J.S., Lee, E.J., et al. 2009. Anti-inflammatory mechanism of ginseng saponins in activated microglia. J. Neuroimmunol. 209(1-2): 40-49. doi:10.1016/j.jneuroim.2009.01.020. PMID:19232442
21. Rafiee, P., Johnson, C.P., Li, M.S., Ogawa, H., Heidemann, J., Fisher, P.J., et al. 2002. Cyclosporine A enhances leukocyte binding by human intestinal microvascular endothelial cells through inhibition of p38 MAPK and iNOS. Paradoxical proinflammatory effect on the microvascular endothelium. J. Biol. Chem. 277(38): 35605-35615. doi:10.1074/jbc.M205826200. PMID:12110686.
22. Rocca, B., and FitzGerald, G.A. 2002. Cyclooxygenases and prostaglandins: shaping up the immune response. Int. Immunopharmacol. 2(5): 603-630. doi:10.1016/S1567-5769(01)00204-1.PMID:12013502.
23. Roshak, A., Jackson, J.R., Chabot-Fletcher, M., and Marshall, L.A. 1997. Inhibition of NFkB-mediated interleukin-1b-stimulated prostaglandin E2 formation by the marine natural product hymenialdisine. J. Pharmacol. Exp. Ther. 283(2): 955-961.PMID:9353419.
24. Sosa, S., Balick, M.J., Arvigo, R., Esposito, R.G., Pizza, C., Altinier, G., and Tubaro, A. 2002. Screening of the topical anti-inflammatory activity of some Central American plants. J. Ethnopharmacol. 81(2): 211-215. doi:10.1016/S0378-8741(02)00080-6. PMID:12065153.
25. Sun, H.X., Qin, F., and Ye, Y.P. 2005. Relationship between haemolytic and adjuvant activity and structure of protopanaxadiol-type saponins from the roots of Panax notoginseng. Vaccine, 23(48-49): 5533-5542. doi:10.1016/j.vaccine.2005.07.036.PMID:16115706.
26. Surh, Y.J., Chun, K.S., Cha, H.H., Han, S.S., Keum, Y.S., Park, K.K., and Lee, S.S. 2001. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: downregulation of COX-2 and iNOS through suppression of NF-kB activation. Mutat. Res. 480-481: 243-268. PMID:11506818
27. Tamir, S., and Tannenbaum, S.R. 1996. The role of nitric oxide (NO) in the carcinogenic process. Biochim. Biophys. Acta, 1288(2): F31-F36. PMID:8876631
28. Tao, X., Ma, L., Mao, Y., and Lipsky, P.E. 1999. Suppression of carrageenan-induced inflammation in vivo by an extract of the Chinese herbal remedy Tripterygium wilfordii Hook F. Inflamm. Res. 48(3): 139-148.doi:10.1007/s000110050437. PMID:10219656
29. Turini, M.E., and DuBois, R.N. 2002. Cyclooxygenase-2: a therapeutic target. Annu. Rev. Med. 53(1): 35-57. doi:10.1146/annurev.med.53.082901.103952. PMID:11818462
30. Wallace, J.L., Chapman, K., and Mcknight, W. 1999. Limited anti-inflammatory efficacy of cyclooxygenase-2 inhibition in carrageenan-airpouch inflammation. Br. J. Pharmacol. 126(5): 1200-1204. doi:10.1038/sj.bjp.0702420. PMID:10205009
31. Wu, C.F., Bi, X.L., Yang, J.Y., Zhan, J.Y., Dong, Y.X., Wang, J.H., et al. 2007. Differential effects of ginsenosides on NO and TNF-α production by LPS-activated N9 microglia. Int. Immunopharmacol. 7(3): 313-320. doi:10.1016/j.intimp.2006.04.021. PMID:17276889
32. Yam, M.F., Asmawi, M.Z., and Basir, R. 2008. An investigation of the anti-inflammatory and analgesic effects of Orthosiphon stamineus leaf extract. J. Med. Food, 11(2): 362-368. doi:10.1089/jmf.2006.065. PMID:18598181
33. Yang, Z., Chen, A., Sun, H., Ye, Y., and Fang, W. 2007. Ginsenoside Rd elicits Th1 and Th2 immune responses to ovalbumin in mice. Vaccine, 25(1): 161-169. doi:10.1016/j.vaccine.2006.05.075.PMID:16950547
34. Yin, H., Zhang, F., Yu, M., Cheng, H., Lin, J., Gao, Y., et al. 2005. Beta endorphin ameliorates synovial cell hyperfunction in the collagen-induced arthritis rat model by specific downregulation of NF-kB activity. Neuroendocrinology, 81(1): 10-18. doi:10.1159/000084828. PMID:15802927
35. Yoshimura, A. 2006. Signal transduction of inflammatory cytokines and tumor development. Cancer Sci. 97(6): 439-447. doi:10.1111/j.1349-7006.2006.00197.x. PMID:16734720
36. Yun, T.K. 2001. Brief introduction of Panax ginseng C.A. Meyer. J. Korean Med. Sci. 16(Suppl.): S3-S5. PMID:11748372